Android app Apple app link

Inhibikase Therapeutics, Inc. (IKT) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$1.50

$0.07 (-4.46%)
Last update: 12:45 PM EST
Day's range
$1.5
Day's range
$1.6

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
12/11/2025 Cantor Fitzgerald Olivia Brayer $4.00 $1.50   166.7%
11/08/2024 Jefferies Dennis Ding $8.00 $2.78   187.77%
10/11/2024 H.C. Wainwright Edward White $5.00 $1.42   252.09%

Inhibikase Therapeutics, Inc. FAQ's

Inhibikase Therapeutics, Inc. has been rated by research analysts at Cantor Fitzgerald, Jefferies, H.C. Wainwright in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.